Eleni Variami Selected Research

COVID-19 Vaccines

1/2022

Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleni Variami Research Topics

Disease

3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 01/2002
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2014 - 09/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022 - 01/2022
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 03/2016
2	Lymphoma (Lymphomas) 01/2018 - 08/2014
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2016 - 08/2013
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2015 - 04/2002
2	Epstein-Barr Virus Infections 08/2014 - 09/2013
1	Ascites 02/2024
1	Paraproteinemias (Monoclonal Gammopathy) 02/2024
1	Polycythemia (Erythrocytosis) 02/2024
1	Telangiectasis (Telangiectasia) 02/2024
1	COVID-19 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Infections 01/2022
1	Essential Thrombocythemia 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2019
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2002
1	Thrombocytopenia (Thrombopenia) 01/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2002
1	Cytopenia 01/2002
1	Hemolysis 01/2002
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2002

Drug/Important Bio-Agent (IBA)

3	Membrane Proteins (Integral Membrane Proteins)IBA 08/2014 - 09/2013
2	BNT162 VaccineIBA 12/2022 - 01/2022
2	VaccinesIBA 12/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 02/2014
2	Azacitidine (5 Azacytidine)FDA Link 01/2019 - 09/2015
1	Immunoglobulin M (IgM)IBA 02/2024
1	COVID-19 VaccinesIBA 01/2022
1	CalreticulinIBA 01/2019
1	ElementsIBA 01/2018
1	CytokinesIBA 01/2017
1	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 05/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	Dacarbazine (DIC)FDA LinkGeneric 03/2016
1	Vinblastine (Vinblastine Sulfate)FDA Link 03/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 03/2016
1	Oncogene Proteins (Oncogene Protein)IBA 08/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2014
1	SurvivinIBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 09/2013
1	Tyrosine Kinase InhibitorsIBA 08/2013
1	Imatinib Mesylate (Gleevec)FDA Link 08/2013
1	nilotinib FDA Link 08/2013
1	Dasatinib (BMS 354825)FDA Link 08/2013
1	Sucrose (Saccharose)IBA 04/2002
1	AntigensIBA 04/2002
1	5,6-dihydroxy-2-dimethylaminotetralin (M 7)IBA 04/2002
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2002
1	Danazol (Azol)FDA LinkGeneric 01/2002

Therapy/Procedure

2	Therapeutics 05/2016 - 01/2002
1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 01/2022